Agilent Acquires MassCode IP for Multiplex PCR, Plans to Commercialize Infectious Disease Panels | GenomeWeb

By Bernadette Toner

This story was originally posted Nov. 24.

Agilent Technologies' recent acquisition of the MassCode Tag assets from Eurofins MWG Operon gives it a labeling technology for multiplexed PCR that should appeal to the basic research market, as well as an opportunity for the firm to launch its own line of panels for infectious disease screening, a company official told PCR Insider.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.